Inflammaging and Cancer: A challenge for the mediterranean diet

Nutrients

Volumn 7, Issue 4, 2015, Pages 2589-2621

  Ostan, Rita ^a   Lanzarini, Catia ^a   Pini, Elisa ^a   Scurti, Maria ^a   Vianello, Dario ^a   Bertarelli, Claudia ^a   Fabbri, Cristina ^a   Izzi, Massimo ^a   Palmas, Giustina ^a   Biondi, Fiammetta ^a   Martucci, Morena ^a   Bellavista, Elena ^a   Salvioli, Stefano ^a   Capri, Miriam ^a   Franceschi, Claudio ^a,b,c   Santoro, Aurelia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b IRCCS   (Italy)

^c CNR   (Italy)

Author keywords

Aging; Cancer; Inflammaging; Inflammation; Mediterranean diet; MicroRNAs; NU AGE project; Nutrients

Indexed keywords

FREE RADICAL; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MONOUNSATURATED FATTY ACID; PLANT MEDICINAL PRODUCT; POLYUNSATURATED FATTY ACID; RESVERATROL; VITAMIN; VITAMIN B GROUP;

AGING; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER RISK; CANCER STAGING; CARBOHYDRATE ANALYSIS; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); DIETARY FIBER; DIETARY INTAKE; EPIGENETICS; GENE MUTATION; HOMEOSTASIS; HUMAN; INFECTION; INFLAMMAGING; INFLAMMATION; INTESTINE FLORA; LIFESTYLE; LIPID COMPOSITION; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PLANT; REVIEW; SYSTEMS BIOLOGY; CHRONIC DISEASE; GASTROINTESTINAL TRACT; MICROBIOLOGY; NEOPLASMS;

AGING; CHRONIC DISEASE; DIET, MEDITERRANEAN; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; NEOPLASMS;

EID: 84927919454     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7042589     Document Type: Review

References (221)

1. López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The hallmarks of aging. Cell 2013, 153, 1194-1217.
2. Franceschi, C.; Bonafè, M.; Valensin, S.; Olivieri, F.; de Luca, M.; Ottaviani, E.; de Benedictis, G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 2000, 908, 244-254.
3. Franceschi, C.; Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69, 4-9.
4. Kennedy, B.K.; Berger, S.L.; Brunet, A.; Campisi, J.; Cuervo, A.M.; Epel, E.S.; Franceschi, C.; Lithgow, G.J.; Morimoto, R.I.; Pessin, J.E.; et al. Geroscience: Linking aging to chronic disease. Cell 2014, 159, 709-713.
5. Franceschi, C. Inflammaging as a major characteristic of old people: Can it be prevented or cured? Nutr. Rev. 2007, 65, 173-176.
6. Franceschi, C.; Capri, M.; Monti, D.; Giunta, S.; Olivieri, F.; Sevini, F.; Panourgia, M.P.; Invidia, L.; Celani, L.; Scurti, M.; et al. Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing. Dev. 2007, 128, 92-105.
7. Cevenini, E.; Monti, D.; Franceschi, C. Inflammaging. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 14-20.
8. Reedy, J. Galen on cancer and related diseases. Clio Med. 1975, 10, 227-238.
9. Trinchieri, G. Cancer and inflammation: An old intuition with rapidly evolving new concepts. Annu. Rev. Immunol. 2012, 30, 677-706.
10. Virchow, R. Cellular Pathology as Based upon Physiological and Pathological Histology; J.B. Lippincott: Philadelphia, PA, USA, 1863.
11. Balkwill, F.; Mantovani, A. Inflammation and cancer: Back to Virchow? Lancet 2001, 357, 539-545.
12. Hanahan, D.; Weinberg, R.A. The Hallmarks of Cancer. Cell 2000, 100, 57-70.
13. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
14. Luo, J.L.; Tan, W.; Ricono, J.M.; Korchynskyi, O.; Zhang, M.; Gonias, S.L.; Cheresh, D.A.; Karin, M. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007, 446, 690-694.
15. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454, 436-444.
16. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674
17. Karin, M. Nuclear factor-κB in cancer development and progression. Nature 2006, 441, 431-436.
18. Chia, W.K.; Ali, R.; Toh, H.C. Aspirin as adjuvant therapy for colorectal cancer-Reinterpreting paradigms. Nat. Rev. Clin. Oncol. 2012, 9, 561-570.
19. Giraldo, N.A.; Becht, E.; Remark, R.; Damotte, D.; Sautès-Fridman, C.; Fridman, W.H. The immune contexture of primary and metastatic human tumours. Curr. Opin. Immunol. 2014, 27, 8-15.
20. Hussain, S.P.; Hofseth, L.J.; Harris, C.C. Radical causes of cancer. Nat. Rev. Cancer 2003, 3, 276-285.
21. Colotta, F.; Allavena, P.; Sica, A.; Garlanda, C.; Mantovani, A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 2009, 30, 1073-1081.
22. Grivennikov, S.I.; Greten, F.R.; Karin, M. Immunity, inflammation, and cancer. Cell 2010, 140, 883-899.
23. Aggarwal, B.B.; Gehlot, P. Inflammation and cancer: How friendly is the relationship for cancer patients? Curr. Opin. Pharmacol. 2009, 9, 351-369.
24. Multhoff, G.; Molls, M.; Radons, J. Chronic inflammation in cancer development. Front. Immunol. 2012, 2, 98.
25. De Lerma Barbaro, A.; Perletti, G.; Bonapace, I.M.; Monti, E. Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (review). Int. J. Oncol. 2014, 45, 959-968.
26. Salvioli, S.; Monti, D.; Lanzarini, C.; Conte, M.; Pirazzini, C.; Bacalini, M.G.; Garagnani, P.; Giuliani, C.; Fontanesi, E.; Ostan, R.; et al. Immune system, cell senescence, aging and longevity-inflamm-aging reappraised. Curr. Pharm. Des. 2013, 19, 1675-1679.
27. Bonafè, M.; Storci, G.; Franceschi, C. Inflamm-aging of the stem cell niche: Breast cancer as a paradigmatic example: Breakdown of the multi-shell cytokine network fuels cancer in aged people. Bioessays 2012, 34, 40-49.
28. Diakos, C.I.; Charles, K.A.; McMillan, D.C.; Clarke, S.J. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014, 15, 493-503.
29. Cevenini, E.; Caruso, C.; Candore, G.; Capri, M.; Nuzzo, D.; Duro, G.; Rizzo, C.; Colonna-Romano, G.; Lio, D.; di Carlo, D.; et al. Age-related inflammation: The contribution of different organs, tissues and systems. How to face it for therapeutic approaches. Curr. Pharm. Des. 2010, 16, 609-618.
30. Ostan, R.; Bucci, L.; Capri, M.; Salvioli, S.; Scurti, M.; Pini, E.; Monti, D.; Franceschi, C. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 2008, 15, 224-240.
31. Grignolio, A.; Franceschi, C. History of Research into Aging/Senescence; John Wiley & Sons: Chichester, UK, 2012.
32. Wellen, K.E.; Fucho, R.; Gregor, M.F.; Furuhashi, M.; Morgan, C.; Lindstad, T.; Vaillancourt, E.; Gorgun, C.Z.; Saatcioglu, F.; Hotamisligil, G.S. Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 2007, 129, 537-548.
33. Erridge, C.; Attina, T.; Spickett, C.M.; Webb, D.J. A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 2007, 86, 1286-1292.
34. Cani, P.D.; Amar, J.; Iglesias, M.A.; Poggi, M.; Knauf, C.; Bastelica, D.; Neyrinck, A.M.; Fava, F.; Tuohy, K.M.; Chabo, C.; et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
35. Gregor, M.F.; Hotamisligil, G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29, 415-445.
36. De Martel, C.; Franceschi, S. Infections and cancer: Established associations and new hypotheses. Crit. Rev. Oncol. Hematol. 2009, 70, 183-194.
37. De Visser, K.E.; Eichten, A.; Coussens, L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 2006, 6, 24-37.
38. Lu, H.; Ouyang, W.; Huang, C. Inflammation, a key event in cancer development. Mol. Cancer Res. 2006, 4, 221-233.
39. Macarthur, M.; Hold, G.L.; El-Omar, E.M. Inflammation and Cancer II. Role of chronic inflammation and cytokine polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286, G515-G520.
40. Whitcomb, D.C. Inflammation and Cancer V. chronic pancreatitis and pancreatic cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287, 315-319.
41. Baan, R.; Grosse, Y.; Straif, K.; Secretan, B.; El Ghissassi, F.; Bouvard, V. A review of human carcinogens Part F. Chemical agents and related occupations. Lancet Oncol. 2009, 10, 1143-1144.
42. Houghton, A.M. Mechanistic links between COPD and lung cancer. Nat. Rev. Cancer 2013, 13, 233-245.
43. Askling, J.; Grunewald, J.; Eklund, A.; Hillerdal, G.; Ekbom, A. Increased risk for cancer following sarcoidosis. Am. J. Respir. Crit. Care Med. 1999, 160, 1668-1672.
44. Calder, P.C.; Ahluwalia, N.; Brouns, F.; Buetler, T.; Clement, K.; Cunningham, K.; Esposito, K.; Jönsson, L.S.; Kolb, H.; Lansink, M.; et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 2011, 106, S5-S78.
45. Wolk, A.; Gridley, G.; Svensson, M.; Nyrén, O.; McLaughlin, J.K.; Fraumeni, J.F.; Adam, H.O. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001, 12, 13-21.
46. Calle, E.E.; Rodriguez, C.; Walker-Thurmond, K.; Thun, M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003, 348, 1625-1638.
47. Renehan, A.G.; Tyson, M.; Egger, M.; Heller, R.F.; Zwahlen, M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371, 569-578.
48. Basen-Engquist, K.; Chang, M. Obesity and cancer risk: Recent review and evidence. Curr. Oncol. Rep. 2011, 13, 71-76.
49. Karagozian, R.; Derdák, Z.; Baffy, G. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism 2014, 63, 607-617.
50. Vitale, G.; Salvioli, S.; Franceschi, C. Oxidative stress and the ageing endocrine system. Nat. Rev. Endocrinol. 2013, 9, 228-240.
51. Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 2010, 49, 1603-1616.
52. Mantovani, A. Cancer: inflammation by remote control. Nature 2005, 435, 752-753.
53. Lin, W.W.; Karin, M.A. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Investig. 2007, 117, 1175-1183.
54. Hoesel, B.; Schmid, J.A. The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer 2013, 2, 12-86.
55. Tieri, P.; Termanini, A.; Bellavista, E.; Salvioli, S.; Capri, M.; Franceschi, C. Charting the NF-κB pathway interactome map. PLoS ONE 2012, 7, e32678.
56. Aggarwal, B.B.; Sung, B. NF-κB in cancer: A matter of life and death. Cancer Discov. 2011, 1, 469-471.
57. Fan, Y.; Mao, R.; Yang, J. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell 2013, 4, 176-185.
58. Freund, A.; Orjalo, A.V.; Desprez, P.Y.; Campisi, J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 2010, 16, 238-246.
59. Olivieri, F.; Lazzarini, R.; Recchioni, R.; Marcheselli, F.; Rippo, M.R.; di Nuzzo, S.; Albertini, M.C.; Graciotti, L.; Babini, L.; Mariotti, S.; et al. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr) 2012, 35, 1157-1172.
60. Rodier, F.; Campisi, J. Four faces of cellular senescence. J. Cell Biol. 2011, 192, 547-556.
61. Martin, O.A.; Redon, C.E.; Dickey, J.S.; Nakamura, A.J.; Bonner, W.M. Para-inflammation mediates systemic DNA damage in response to tumor growth. Commun. Integr. Biol. 2011, 4, 78-81.
62. Bellavista, E.; Andreoli, F.; Parenti, M.D.; Martucci, M.; Santoro, A.; Salvioli, S.; Capri, M.; Baruzzi, A.; Del Rio, A.; Franceschi, C.; et al. Immunoproteasome in cancer and neuropathologies: a new therapeutic target? Curr. Pharm. Des. 2013, 19, 702-718.
63. Bellavista, E.; Martucci, M.; Vasuri, F.; Santoro, A.; Mishto, M.; Kloss, A.; Capizzi, E.; Degiovanni, A.; Lanzarini, C.; Remondini, D.; et al. Lifelong maintenance of composition, function and cellular/subcellulardistribution of proteasomes in human liver. Mech. Ageing Dev. 2014, 141-142, 26-34.
64. Morimoto, R.I.; Cuervo, A.M. Proteostasis and the aging proteome in health and disease. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69, 33-38.
65. Keys, A.; Arvanis, C.; Blackburn, H. Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease; Harvard University Press: Cambridge, MA, USA, 1980.
66. Estruch, R.; Ros, E.; Salas-Salvadó, J.; Covas, M.I.; Corella, D.; Arós, F.; Gómez-Gracia, E.; Ruiz-Gutiérrez, V.; Fiol, M.; Lapetra, J.; et al. PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 2013, 368, 1279-1290.
67. Bonaccio, M.; di Castelnuovo, A.; de Curtis, A.; Costanzo, S.; Persichillo, M.; Donati, M.B.; Cerletti, C.; Iacoviello, L.; de Gaetano, G. Moli-sani Project Investigators. Adherence to the Mediterranean diet is associated with lower platelet and leukocyte counts: Results from the Moli-sani study. Blood 2014, 123, 3037-3044.
68. Trichopoulou, A.; Orfanos, P.; Norat, T.; Bueno-de-Mesquita, B.; Ocké, M.C.; Peeters, P.H.; van der Schouw, Y.T.; Boeing, H.; Hoffmann, K.; Boffetta, P.; et al. Modified Mediterranean diet and survival: EPIC-elderly prospective cohort study. BMJ 2005, 330, 991.
69. Mente, A.; de Koning, L.; Shannon, H.S.; Anand, S.S. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch. Intern. Med. 2009, 169, 659-669.
70. Trichopoulou, A.; Costacou, T.; Bamia, C.; Trichopoulos, D. Adherence to a Mediterranean diet and survival in a Greek population. N. Engl. J. Med. 2003, 348, 2599-2608.
71. Misirli, G.; Benetou, V.; Lagiou, P.; Bamia, C.; Trichopoulos, D.; Trichopoulou, A. Relation of the traditional Mediterranean diet to cerebrovascular disease in a Mediterranean population. Am. J. Epidemiol. 2012, 176, 1185-1192.
72. Benetou, V.; Trichopoulou, A.; Orfanos, P.; Naska, A.; Lagiou, P.; Boffetta, P.; Trichopoulos, D.; Greek, E. Conformity to traditional Mediterranean diet and cancer incidence: The Greek EPIC cohort. Br. J. Cancer 2008, 99, 191-195.
73. Couto, E.; Boffetta, P.; Lagiou, P.; Ferrari, P.; Buckland, G.; Overvad, K.; Dahm, C.C.; Tjonneland, A.; Olsen, A.; Clavel-Chapelon, F.; et al. Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br. J. Cancer 2011, 104, 1493-1499.
74. Brand-Miller, J.; Dickinson, S.; Barclay, A.; Celermajer, D. The glycemic index and cardiovascular disease risk. Curr. Atheroscler. Rep. 2007, 9, 479-485.
75. Mirrahimi, A.; Chiavaroli, L.; Srichaikul, K.; Augustin, L.S.; Sievenpiper, J.L.; Kendall, C.W.; Jenkins, D.J. The role of glycemic index and glycemic load in cardiovascular disease and its risk factors: A review of the recent literature. Curr. Atheroscler. Rep. 2014, 16, 381.
76. Sofi, F.; Macchi, C.; Abbate, R.; Gensini, G.F.; Casini, A. Mediterranean diet and health. Biofactors 2013, 39, 335-342.
77. De Vrese, M.; Schrezenmeir, J. Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 2008, 111, 1-66.
78. De Lorgeril, M.; Salen, P. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med. 2012, 10, 50.
79. Kalogeropoulos, N.; Chiou, A.; Ioannou, M.S.; Karathanos, V.T. Nutritional evaluation and health promoting activities of nuts and seeds cultivated in Greece. Int. J. Food Sci. Nutr. 2013, 64, 757-767.
80. Zamora-Ros, R.; Serafini, M.; Estruch, R.; Lamuela-Raventós, R.M.; Martínez-González, M.A.; Salas-Salvadó, J.; Fiol, M.; Lapetra, J.; Arós, F.; Covas, M.I.; et al. PREDIMED Study Investigators. Mediterranean diet and non enzymatic antioxidant capacity in the PREDIMED study: Evidence for a mechanism of antioxidant tuning. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 1167-1174.
81. Kolomvotsou, A.I.; Rallidis, L.S.; Mountzouris, K.C.; Lekakis, J.; Koutelidakis, A.; Efstathiou, S.; Nana-Anastasiou, M.; Zampelas, A. Adherence to Mediterranean diet and close dietetic supervision increase total dietary antioxidant intake and plasma antioxidant capacity in subjects with abdominal obesity. Eur. J. Nutr. 2013, 52, 37-48.
82. Trichopoulou, A.; Martínez-González, M.A.; Tong, T.Y.; Forouhi, N.G.; Khandelwal, S.; Prabhakaran, D.; Mozaffarian, D.; de Lorgeril, M. Definitions and potential health benefits of the Mediterranean diet: views from experts around the world. BMC Med. 2014, 12, 112.
83. Trichopoulou, A.; Kouris-Blazos, A.; Wahlqvist, M.L.; Gnardellis, C.; Lagiou, P.; Polychronopoulos, E.; Vassilakou, T.; Lipworth, L.; Trichopoulos, D. Diet and overall survival in elderly people. BMJ 1995, 311, 1457-1460.
84. Bosire, C.; Stampfer, M.J.; Subar, A.F.; Park, Y.; Kirkpatrick, S.I.; Chiuve, S.E.; Hollenbeck, A.R.; Reedy, J. Index-based dietary patterns and the risk of prostate cancer in the NIH-AARP diet and health study. Am. J. Epidemiol. 2013, 177, 504-513.
85. Mitrou, P.N.; Kipnis, V.; Thiébaut, A.C.; Reedy, J.; Subar, A.F.; Wirfält, E.; Flood, A.; Mouw, T.; Hollenbeck, A.R.; Leitzmann, M.F.; et al.Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch. Intern. Med. 2007, 167, 2461-2468.
86. Schwingshackl, L.; Hoffmann, G. Adherence to Mediterranean diet and risk of cancer: A systematic review and meta-analysis of observational studies. Int. J. Cancer 2014, 135, 1884-1897.
87. Grosso, G.; Biondi, A.; Galvano, F.; Mistretta, A.; Marventano, S.; Buscemi, S.; Drago, F.; Basile, F. Factors associated with colorectal cancer in the context of the Mediterranean diet: A case-control study. Nutr. Cancer 2014, 66, 558-565.
88. Agnoli, C.; Grioni, S.; Sieri, S.; Palli, D.; Masala, G.; Sacerdote, C.; Vineis, P.; Tumino, R.; Giurdanella, M.C.; Pala, V.; et al. Italian Mediterranean Index and risk of colorectal cancer in the Italian section of the EPIC cohort. Int. J. Cancer 2013, 132, 1404-1411.
89. Reedy, J.; Mitrou, P.N.; Krebs-Smith, S.M.; Wirfält, E.; Flood, A.; Kipnis, V.; Leitzmann, M.; Mouw, T.; Hollenbeck, A.; Schatzkin, A.; et al. Index-based dietary patterns and risk of colorectal cancer: the NIH-AARP Diet and Health Study. Am. J. Epidemiol. 2008, 168, 38-48.
90. Kenfield, S.A.; DuPre, N.; Richman, E.L.; Stampfer, M.J.; Chan, J.M.; Giovannucci, E.L. Mediterranean diet and prostate cancer risk and mortality in the health professionals follow-up study. Eur. Urol. 2014, 65,887-894.
91. Filomeno, M.; Bosetti, C.; Garavello, W.; Levi, F.; Galeone, C.; Negri, E.; la Vecchia, C. The role of a Mediterranean diet on the risk of oral and pharyngeal cancer. Br. J. Cancer 2014, 111, 981-986.
92. Bosetti, C.; Gallus, S.; Trichopoulou, A.; Talamini, R.; Franceschi, S.; Negri, E.; la Vecchia, C. Influence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol. Biomarkers Prev. 2003, 12, 1091-1094.
93. Samoli, E.; Lagiou, A.; Nikolopoulos, E.; Lagogiannis, G.; Barbouni, A.; Lefantzis, D.; Trichopoulos, D.; Brennan, P.; Lagiou, P. Mediterranean diet and upper aerodigestive tract cancer: the Greek segment of the Alcohol-Related Cancers and Genetic Susceptibility in Europe study. Br. J. Nutr. 2010, 104, 1369-1374.
94. Mourouti, N.; Papavagelis, C.; Plytzanopoulou, P.; Kontogianni, M.; Vassilakou, T.; Malamos, N.; Linos, A.; Panagiotakos, D. Dietary patterns and breast cancer: A case-control study in women. Eur. J. Nutr. 2014, in press.
95. De la Torre-Carbot, K.; Chávez-Servín, J.L.; Jaúregui, O.; Castellote, A.I.; Lamuela-Raventós, R.M.; Nurmi, T.; Poulsen, H.E.; Gaddi, A.V.; Kaikkonen, J.; Zunft, H.F.; et al. Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. J. Nutr. 2010, 140, 501-508.
96. Camargo, A.; Delgado-Lista, J.; Garcia-Rios, A.; Cruz-Teno, C.; Yubero-Serrano, E.M.; Perez-Martinez, P.; Gutierrez-Mariscal, F.M.; Lora-Aguilar, P.; Rodriguez-Cantalejo, F.; Fuentes-Jimenez, F.; et al. Expression of proinflammatory, proatherogenic genes is reduced by the Mediterranean diet in elderly people. Br. J. Nutr. 2012, 108, 500-508.
97. Aggarwal, B.B.; Shisodia, S. Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann. N.Y. Acad. Sci. 2004, 1030, 434-441.
98. Santangelo, C.; Varì, R.; Scazzocchio, B.; Di Benedetto, R.; Filesi, C.; Masella, R. Polyphenols, intracellular signalling and inflammation. Ann. Ist. Super Sanita 2007, 43, 394-405.
99. Laughton, M.J.; Evans, P.J.; Moroney, M.A.; Hoult, J.R.; Halliwell, B. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol. 1991, 42, 1673-1681.
100. Ferrándiz, M.L.; Alcaraz, M.J. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 1991, 32, 283-288.
101. Kim, H.P.; Mani, I.; Iversen, L.; Ziboh, V.A. Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. Prostaglandins Leukot. Essent. Fatty Acids 1998, 58, 17-24.
102. Chondrogianni, N.; Kapeta, S.; Chinou, I.; Vassilatou, K.; Papassideri, I.; Gonos, E.S. Anti-ageing and rejuvenating effects of quercetin. Exp. Gerontol. 2010, 45, 763-771.
103. Scoditti, E.; Calabriso, N.; Massaro, M.; Pellegrino, M.; Storelli, C.; Martines, G.; de Caterina, R.; Carluccio, M.A. Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 2012, 527, 81-89.
104. Liang, Y.C.; Huang, Y.T.; Tsai, S.H.; Lin-Shiau, S.Y.; Chen, C.F.; Lin, J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999, 20, 1945-1952.
105. Kim, H.K.; Cheon, B.S.; Kim, Y.H.; Kim, S.Y.; Kim, H.P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol. 1999, 58, 759-765.
106. Chen, Y.C.; Shen, S.C.; Lee, W.R.; Hou, W.C.; Yang, L.L.; Lee, T.J. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. J. Cell Biochem. 2001, 82, 537-548.
107. Miles, E.A.; Zoubouli, P.; Calder, P.C. Differential anti-inflammatory effects of phenolic compounds from extra virgin olive oil identified in human whole blood cultures. Nutrition 2005, 21, 389-394.
108. Calixto, J.B.; Campos, M.M.; Otuki, M.F.; Santos, A.R. Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Plant. Med. 2004, 70, 93-103.
109. Comalada, M.; Ballester, I.; Bailón, E.; Sierra, S.; Xaus, J.; Gálvez, J.; de Medina, F.S.; Zarzuelo, A. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structure-activity relationship. Biochem. Pharmacol. 2006, 72, 1010-1021.
110. Blonska, M.; Czuba, Z.P.; Krol, W. Effect of flavone derivatives on interleukin-1beta (IL-1beta) mRNA expression and IL-1beta protein synthesis in stimulated RAW 264.7 macrophages. Scand. J. Immunol. 2003, 57, 162-166.
111. Sharma, V.; Mishra, M.; Ghosh, S.; Tewari, R.; Basu, A.; Seth, P.; Sen, E. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection. Brain Res. Bull. 2007, 73, 55-63.
112. Min, Y.D.; Choi, C.H.; Bark, H.; Son, H.Y.; Park, H.H.; Lee, S.; Park, J.W.; Park, E.K.; Shin, H.I.; Kim, S.H. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res. 2007, 5, 210-215.
113. Rahman, I.; Biswas, S.K.; Kirkham, P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 2006, 72, 1439-1452.
114. Benvenuto, M.; Fantini, M.; Masuelli, L.; de Smaele, E.; Zazzeroni, F.; Tresoldi, I.; Calabrese, G.; Galvano, F.; Modesti, A.; Bei, R. Inhibition of ErbB receptors, Hedgehog and NF-kappaB signaling by polyphenols in cancer. Front. Biosci. (Landmark Ed.) 2013, 18, 1290-1310.
115. Chen, C.C.; Chow, M.P.; Huang, W.C.; Lin, Y.C.; Chang, Y.J. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: Structure-activity relationships. Mol. Pharmacol. 2004, 66, 683-693.
116. Huang, S.M.; Wu, C.H.; Yen, G.C. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs. Mol. Nutr. Food. Res. 2006, 50, 1129-1139.
117. Pallauf, K.; Giller, K.; Huebbe, P.; Rimbach, G. Nutrition and healthy ageing: Calorie restriction or polyphenol-rich “MediterrAsian” diet? Oxid. Med. Cell. Longev. 2013, 2013, 707421.
118. Bruning, A. Inhibition of mTOR signaling by quercetin in cancer treatment and prevention. Anticancer Agents Med. Chem. 2013, 13, 1025-1031.
119. Galli, M.; van Gool, F.; Leo, O. Sirtuins and inflammation: friends or foes? Biochem. Pharmacol. 2011, 81, 569-576.
120. Horio, Y.; Hayashi, T.; Kuno, A.; Kunimoto, R. Cellular and molecular effects of sirtuins in health and disease. Clin. Sci. (Lond) 2011, 121, 191-203.
121. Yeung, F.; Hoberg, J.E.; Ramsey, C.S.; Keller, M.D.; Jones, D.R.; Frye, R.A.; Mayo, M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23, 2369-2380.
122. Kawahara, T.L.; Michishita, E.; Adler, A.S.; Damian, M.; Berber, E.; Lin, M.; McCord, R.A.; Ongaigui, K.C.; Boxer, L.D.; Chang, H.Y.; et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009, 136, 62-74.
123. Alhazzazi, T.Y.; Kamarajan, P.; Verdin, E.; Kapila, Y.L. Sirtuin-3 (SIRT3) and the Hallmarks of Cancer. Genes Cancer 2013, 4, 164-171.
124. Van Gool, F.; Galli, M.; Gueydan, C.; Kruys, V.; Prevot, P.P.; Bedalov, A.; Mostoslavsky, R.; Alt, F.W.; de Smedt, T.; Leo, O. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat. Med. 2009, 15, 206-210.
125. Parbin, S.; Kar, S.; Shilpi, A.; Sengupta, D.; Deb, M.; Rath, S.K.; Patra, S.K. Histone deacetylases: A saga of perturbed acetylation homeostasis in cancer. J. Histochem. Cytochem. 2014, 62, 11-33.
126. Song, N.Y.; Surh, Y.J. Janus-faced role of SIRT1 in tumorigenesis. Ann. N. Y. Acad. Sci. 2012, 1271, 10-19.
127. Bayram, B.; Ozcelik, B.; Grimm, S.; Roeder, T.; Schrader, C.; Ernst, I.M.; Wagner, A.E.; Grune, T.; Frank, J.; Rimbach, G. A diet rich in olive oil phenolics in the heart of SAMP8 mice by induction of Nrf2-dependent gene expression. Rejuvenation Res. 2012, 15, 71-81.
128. Menendez, J.A.; Joven, J.; Aragonès, G.; Barrajón-Catalán, E.; Beltrán-Debón, R.; Borrás-Linares, I.; Camps, J.; Corominas-Faja, B.; Cufí, S.; Fernández-Arroyo, S.; et al. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: A new family of gerosuppressant agents. Cell Cycle 2013, 12, 555-578.
129. Popat, R.; Plesner, T.; Davies, F.; Cook, G.; Cook, M.; Elliott, P.; Jacobson, E.; Gumbleton, T.; Oakervee, H.; Cavenagh, J. A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. Br. J. Haematol. 2013, 160, 714-717.
130. Bohn, T. Dietary factors affecting polyphenol bioavailability. Nutr. Rev. 2014, 72, 429-452.
131. Holzapfel, N.P.; Holzapfel, B.M.; Champ, S.; Feldthusen, J.; Clements, J.; Hutmacher, D.W. The potential role of lycopene for the prevention and therapy of prostate cancer: from molecular mechanisms to clinical evidence. Int. J. Mol. Sci. 2013, 14, 14620-14646.
132. Bjelakovic, G.; Nikolova, D.; Gluud, C. Antioxidant supplements and mortality. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17, 40-44.
133. Ma, Y.; Hébert, J.R.; Li, W.; Bertone-Johnson, E.R.; Olendzki, B.; Pagoto, S.L.; Tinker, L.; Rosal, M.C.; Ockene, I.S.; Ockene, J.K.; et al. Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study. Nutrition 2008, 24, 941-949.
134. Ma, Y.; Griffith, J.A.; Chasan-Taber, L.; Olendzki, B.C.; Jackson, E.; Stanek, E.J., 3rd; Li, W.; Pagoto, S.L.; Hafner, A.R.; Ockene, I.S. Association between dietary fiber and serum C-reactive protein. Am. J. Clin. Nutr. 2006, 83, 760-766.
135. Chuang, S.C.; Vermeulen, R.; Sharabiani, M.T.; Sacerdote, C.; Fatemeh, S.H.; Berrino, F.; Krogh, V.; Palli, D.; Panico, S.; Tumino, R.; et al. The intake of grain fibers modulates cytokine levels in blood. Biomarkers 2011, 16, 504-510.
136. Reddy, B.S.; Hirose, Y.; Cohen, L.A.; Simi, B.; Cooma, I.; Rao, C.V. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res. 2000, 60, 4792-4797.
137. Guigoz, Y.; Rochat, F.; Perruisseau-Carrier, G.; Rochat, I.; Schiffrin, E.J. Effects of oligosaccharide on the faecal flora and nonspecific immune system in elderly people. Nutr. Res. 2002, 22, 13-25.
138. Kaczmarczyk, M.M.; Miller, M.J.; Freund, G.G. The health benefits of dietary fiber: Beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism 2012, 61, 1058-1066.
139. Durko, L.; Malecka-Panas, E. Lifestyle Modifications and Colorectal Cancer. Curr. Colorectal. Cancer Rep. 2014, 10, 45-54.
140. Toner, C.D. Communicating clinical research to reduce cancer risk through diet: Walnuts as a case example. Nutr. Res. Pract. 2014, 8, 347-351.
141. Urpi-Sarda, M.; Casas, R.; Chiva-Blanch, G.; Romero-Mamani, E.S.; Valderas-Martínez, P.; Salas-Salvadó, J.; Covas, M.I.; Toledo, E.; Andres-Lacueva, C.; Llorach, R.; et al. The Mediterranean diet pattern and its main components are associated with lower plasma concentrations of tumor necrosis factor receptor 60 in patients at high risk for cardiovascular disease. J. Nutr. 2012, 142, 1019-1025.
142. Patterson, R.E.; Flatt, S.W.; Newman, V.A.; Natarajan, L.; Rock, C.L.; Thomson, C.A.; Caan, B.J.; Parker, B.A.; Pierce, J.P. Marine fatty acid intake is associated with breast cancer prognosis. J. Nutr. 2011, 141, 201-206.
143. Chapkin, R.S.; Kim, W.; Lupton, J.R.; McMurray, D.N. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot. Essent. Fatty Acids 2009, 81, 187-191.
144. Santarelli, R.L.; Pierre, F.; Corpet, D.E. Processed meat and colorectal cancer: A review of epidemiologic and experimental evidence. Nutr. Cancer 2008, 60, 131-144.
145. Myles, I.A. Fast food fever: reviewing the impacts of the Western diet on immunity. Nutr. J. 2014, 13, 61.
146. Olivieri, F.; Spazzafumo, L.; Santini, G.; Lazzarini, R.; Albertini, M.C.; Rippo, M.R.; Galeazzi, R.; Abbatecola, A.M.; Marcheselli, F.; Monti, D.; et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging.Mech. Ageing Dev. 2012, 133, 675-685.
147. Esquela-Kerscher, A.; Slack, F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6, 259-269.
148. Winter, J.; Jung, S.; Keller, S.; Gregory, R.I.; Diederichs, S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11, 228-234.
149. Tzur, G.; Israel, A.; Levy, A.; Benjamin, H.; Meiri, E.; Shufaro, Y.; Meir, K.; Khvalevsky, E.; Spector, Y.; Rojansky, N.; et al. Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS ONE 2009, 4, e7511.
150. Hussain, S.P.; Harris, C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 2007, 121, 2373-2380.
151. Olivieri, F.; Rippo, M.R.; Monsurrò, V.; Salvioli, S.; Capri, M.; Procopio, A.D.; Franceschi, C. MicroRNAs linking inflamm-aging, cellular senescence and cancer. Ageing Res. Rev. 2013, 12, 1056-1068.
152. Lu, J.; Getz, G.; Miska, E.A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B.L.; Mak, R.H.; Ferrando, A.A.; et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435, 834-838.
153. Piepoli, A.; Tavano, F.; Copetti, M.; Mazza, T.; Palumbo, O.; Panza, A.; di Mola, F.F.; Pazienza, V.; Mazzoccoli, G.; Biscaglia, G.; et al. miRNA expression profiles identify drivers in colorectal and pancreatic cancers. PLoS ONE 2012, 7, e33663.
154. Lu, Y.; Govindan, R.; Wang, L.; Liu, P.Y.; Goodgame, B.; Wen, W.; Sezhiyan, A.; Pfeifer, J.; Li, Y.F.; Hua, X.; et al. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 2012, 33, 1046-1054.
155. Zhang, Y.; Li, M.; Wang, H.; Fisher, W.E.; Lin, P.H.; Yao, Q.; Chen, C. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World. J. Surg. 2009, 33, 698-709.
156. Fenech, M.; El-Sohemy, A.; Cahill, L.; Ferguson, L.R.; French, T.A.; Tai, E.S.; Milner, J.; Koh, W.P.; Xie, L.; Zucker, M.; et al. Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practice. J. Nutrigenet. Nutrigenomics 2011, 4, 69-89.
157. Chang, W.L.; Chapkin, R.S.; Lupton, J.R. Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J. Nutr. 1998, 128, 491-497.
158. Davidson, L.A.; Wang, N.; Ivanov, I.; Goldsby, J.; Lupton, J.R.; Chapkin, R.S. Identification of actively translated mRNA transcripts in a rat model of early-stage colon carcinogenesis. Cancer Prev. Res. 2009, 2, 984-994.
159. Kachroo, P.; Ivanov, I.; Davidson, L.A.; Chowdhary, B.P.; Lupton, J.R.; Chapkin, R.S. Classification of diet-modulated gene signatures at the colon cancer initiation and progression stages. Dig. Dis. Sci. 2011, 5, 2595-2604.
160. Turk, H.F.; Barhoumi, R.; Chapkin, R.S. Alteration of EGFR spatiotemporal dynamics suppresses signal transduction. PLoS ONE 2012, 7, e39682.
161. Dimri, M.; Bommi, P.V.; Sahasrabuddhe, A.A.; Khandekar, J.D.; Dimri, G.P. Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis 2010, 31, 489-495.
162. Leaver, H.A.; Wharton, S.B.; Bell, H.S.; Leaver-Yap, I.M.; Whittle, I.R. Highly unsaturated fatty acid induced tumour regression in glioma pharmacodynamics and bioavailability of gamma linolenic acid in an implantation glioma model: effects on tumour biomass, apoptosis and neuronal tissue histology. Prostaglandins Leukot. Essent. Fatty Acids 2002, 67, 283-292.
163. Reddy, B.S.; Burill, C.; Rigotty, J. Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991, 51, 487-491.
164. Whelan, J.; McEntee, M.F. Dietary (n-6) PUFA and intestinal tumorigenesis. J Nutr. 2004, 134, 3421-3426.
165. Vinciguerra, M.; Sgroi, A.; Veyrat-Durebex, C.; Rubbia-Brandt, L.; Buhler, L.H.; Foti, M. Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology 2009, 49, 1176-1184.
166. Hodin, R.A.; Meng, S.; Archer, S.; Tang, R. Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ. 1996, 7, 647-653.
167. Hinnebusch, B.F.; Meng, S.; Wu, J.T.; Archer, S.Y.; Hodin, R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr. 2002, 132, 1012-1017.
168. Chirakkal, H.; Leech, S.H.; Brookes, K.E.; Prais, A.L.; Waby, J.S.; Corfe, B.M. Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene 2006, 25, 7192-7200.
169. Comalada, M.; Bailón, E.; de Haro, O.; Lara-Villoslada, F.; Xaus, J.; Zarzuelo, A.; Gálvez, J. The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J. Cancer Res. Clin. Oncol. 2006, 132, 487-497.
170. Hu, S.; Dong, T.S.; Dalal, S.R.; Wu, F.; Bissonnette, M.; Kwon, J.H.; Chang, E.B. The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer. PLoS ONE 2011, 6, e16221.
171. Shah, M.S.; Schwartz, S.L.; Zhao, C.; Davidson, L.A.; Zhou, B.; Lupton, J.R.; Ivanov, I.; Chapkin, R.S. Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: Effect of a chemo-protective diet. Physiol. Genomics 2011, 43, 640-654.
172. Sun, Y.; Zuo, L.; Xu, C.; Shen, T.; Pan, H.; Zhang, Z. Apoptosis and differentiation induced by sodium selenite combined with all-trans retinoic acid (ATRA) in NB4 cells. Zhonghua Xue Ye Xue Za Zhi 2002, 23, 628-630.
173. Terao, M.; Fratelli, M.; Kurosaki, M.; Zanetti, A.; Guarnaccia, V.; Paroni, G.; Tsykin, A.; Lupi, M.; Gianni, M.; Goodall, G.J.; et al. Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: Biological correlates and molecular targets. J. Biol. Chem. 2011, 286, 4027-4042.
174. Wang, X.; Gocek, E.; Liu, C.G.; Studzinski, G.P. MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3. Cell Cycle 2009, 8, 736-741.
175. Arts, I.C.; Hollman, P.C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317-325.
176. Scalbert, A.; Manach, C.; Morand, C.; Rémésy, C.; Jiménez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287-306.
177. Schroeter, H.; Heiss, C.; Balzer, J.; Kleinbongard, P.; Keen, C.L.; Hollenberg, N.K.; Sies, H.; Kwik-Uribe, C.; Schmitz, H.H.; Kelm, M. Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA 2006, 103, 1024-1029.
178. Spencer, J.P.; Abd El Mohsen, M.M.; Minihane, A.M.; Mathers, J.C. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br. J. Nutr. 2008, 99, 12-22.
179. Joven, J.; Espinel, E.; Rull, A.; Aragonès, G.; Rodríguez-Gallego, E.; Camps, J.; Micol, V.; Herranz-López, M.; Menéndez, J.A.; Borrás, I.; et al. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim. Biophys. Acta 2012, 1820, 894-899.
180. Sun, M.; Estrov, Z.; Ji, Y.; Coombes, K.R.; Harris, D.H.; Kurzrock, R. Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 2008, 7, 464-473.
181. Bao, B.; Ali, S.; Kong, D.; Sarkar, S.H.; Wang, Z.; Banerjee, S.; Aboukameel, A.; Padhye, S.; Philip, P.A.; Sarkar, F.H. Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS ONE 2011, 6, e17850.
182. Biagi, E.; Candela, M.; Fairweather-Tait, S.; Franceschi, C.; Brigidi, P. Aging of the human metaorganism: the microbial counterpart. Age (Dordr) 2012, 34, 247-267.
183. Claesson, M.J.; Cusack, S.; O'Sullivan, O.; Greene-Diniz, R.; de Weerd, H.; Flannery, E.; Marchesi, J.R.; Falush, D.; Dinan, T.; Fitzgerald, G.; et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. USA 2011, 108, 4586-4591.
184. Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the human intestinal microbial flora. Science 2005, 308, 1635-1638.
185. Candela, M.; Biagi, E.; Brigidi, P.; O'Toole, P.W.; de Vos, W.M. Maintenance of a healthy trajectory of the intestinal microbiome during aging: A dietary approach. Mech. Ageing Dev. 2014, 136-137, 70-75.
186. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222-227.
187. Jeffery, I.B.; O'Toole, P.W. Diet-microbiota interactions and their implications for healthy living. Nutrients 2013, 5, 234-252.
188. Claesson, M.J.; Jeffery, I.B.; Conde, S.; Power, S.E.; O'Connor, E.M.; Cusack, S.; Harris, H.M.; Coakley, M.; Lakshminarayanan, B.; O'Sullivan, O.; et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488,178-284.
189. Turnbaugh, P.J.; Ridaura, V.K.; Faith, J.J.; Rey, F.E.; Knight, R.; Gordon, J.I. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1, 6ra14.
190. Bäckhed, F.; Ley, R.E.; Sonnenburg, J.L.; Peterson, D.A.; Gordon, J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307, 1915-1920.
191. Duncan, S.H.; Belenguer, A.; Holtrop, G.; Johnstone, A.M.; Flint, H.J.; Lobley, G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 2007, 73, 1073-1078.
192. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A.; et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559-563.
193. Biagi, E.; Nylund, L.; Candela, M.; Ostan, R.; Bucci, L.; Pini, E.; Nikkïla, J.M.; Monti, D.; Satokari, R.; Franceschi, C.; et al. Through aging, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE 2010, 5, e10667.
194. Boyle, P.; Ferlay, J. Mortality and survival in breast and colorectal cancer. Nat. Clin. Pract. Oncol. 2005, 2, 424-425.
195. Mladenova, D.; Kohonen-Corish, M.R. Review: Mouse models of inflammatory bowel disease: insights into the mechanisms of inflammation-associated colorectal cancer. In Vivo 2012, 26, 627-646.
196. Nikolaki, S.; Tsiamis, G. Microbial diversity in the era of omic technologies. Biomed. Res. Int. 2013, 2013, 958719.
197. Tjalsma, H.; Boleij, A.; Marchesi, J.R.; Dutilh, B.E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 2012, 10, 575-582.
198. Schwabe, R.F.; Wang, T.C. Cancer. Bacteria deliver a genotoxic hit. Science 2012, 338, 52-53.
199. Nicholson, J.K.; Lindon, J.C. Systems biology: Metabonomics. Nature 2008, 455, 1054-1056.
200. Wishart, D.S.; Knox, C.; Guo, A.C.; Eisner, R.; Young, N.; Gautam, B.; Hau, D.D.; Psychogios, N.; Dong, E.; Bouatra, S.; et al.HMDB: A knowledgebase for the human metabolome. Nucl. Acids Res. 2009, 37, 603-610.
201. Fahy, E.; Subramaniam, S.; Murphy, R.C.; Nishijima, M.; Raetz, C.R.; Shimizu, T.; Spener, F.; van Meer, G.; Wakelam, M.J.; Dennis, E.A. Update of the LIPID MAPS comprehensive classification system for lipids. J. Lipid Res. 2009, 50, 9-14.
202. Vinayavekhin, N.; Homan, E.; Saghatelian, A. Exploring disease through metabolomics. ACS Chem. Biol. 2010, 5, 91-103.
203. Gieger, C.; Geistlinger, L.; Altmaier, E.; Hrabé de Angelis, M.; Kronenberg, F.; Meitinger, T.; Mewes, H.W.; Wichmann, H.E.; Weinberger, K.M.; Adamski, J.; et al. Genetics meets metabolomics: A genome-wide association study of metabolite profiles in human serum. PLoS Genet 2008, 4, e1000282.
204. Chadeau-Hyam, M.; Ebbels, T.M.; Brown, I.J.; Chan, Q.; Stamler, J.; Huang, C.C.; Daviglus, M.L.; Ueshima, H.; Zhao, L.; Holmes, E.; et al. Metabolic profiling and the metabolome-wide association study: significance level for biomarker identification. J. Proteome Res. 2010, 9, 4620-4627.
205. Nicholson, J.K.; Holmes, E.; Elliott, P. The metabolome-wide association study: A new look at human disease risk factors. J Proteome Res 2008, 7, 3637-3638.
206. Bictash, M.; Ebbels, T.M.; Chan, Q.; Loo, R.L.; Yap, I.K.; Brown, I.J.; de Iorio, M.; Daviglus, M.L.; Holmes, E.; Stamler, J.; et al. Opening up the “Black Box”: Metabolic phenotyping and metabolome-wide association studies in epidemiology. J. Clin. Epidemiol. 2010, 63, 970-979.
207. Watson, E.; MacNeil, L.T.; Ritter, A.D.; Yilmaz, L.S.; Rosebrock, A.P.; Caudy, A.A.; Walhout, A.J. Interspecies systems biology uncovers metabolites affecting C. elegans gene expression and life history traits. Cell 2014, 156, 759-770.
208. Nookaew, I.; Gabrielsson, B.G.; Holmäng, A.; Sandberg, A.S.; Nielsen, J. Identifying molecular effects of diet through systems biology: Influence of herring diet on sterol metabolism and protein turnover in mice. PLoS ONE 2010, 5, e12361.
209. Griffin, J.L.; Shockcor, J.P. Metabolic profiles of cancer cells. Nat. Rev. Cancer 2004, 4, 551-561.
210. Spratlin, J.L.; Serkova, N.J.; Eckhardt, S.G. Clinical applications of metabolomics in oncology: A review. Clin. Cancer Res. 2009, 15, 431-440.
211. Tieri, P.; de la Fuente, A.; Termanini, A.; Franceschi, C. Integrating Omics data for signaling pathways, interactome reconstruction, and functional analysis. Methods Mol. Biol. 2011, 719, 415-433.
212. Sreekumar, A.; Poisson, L.M.; Rajendiran, T.M.; Khan, A.P.; Cao, Q.; Yu, J.; Laxman, B.; Mehra, R.; Lonigro, R.J.; Li, Y.; et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457, 910-914.
213. De Boer, N.K.H.; de Meij, T.G.; Oort, F.A.; Ben Larbi, I.; Mulder, C.J.; van Bodegraven, A.A.; van der Schee, M.P. The Scent of Colorectal Cancer: Detection by Volatile Organic Compound Analysis. Clin. Gastroenterol. Hepatol. 2014, 12, 1085-1089.
214. Floegel, A.; Wientzek, A.; Bachlechner, U.; Jacobs, S.; Drogan, D.; Prehn, C.; Adamski, J.; Krumsiek, J.; Schulze, M.B.; Pischon, T.; et al. Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study. Int. J. Obes. (Lond) 2014, 38, 1388-1396.
215. Eurostat. Available online: http://ec.europa.eu/eurostat/help/new-eurostat-website (accessed on 7 April 2015).
216. The European Project NU-AGE (FP7, n° 266486; 2011-2016). Available online: http://www. nu-age.eu (accessed on 7 April 2015).
217. Santoro, A.; Pini, E.; Scurti, M.; Palmas, G.; Berendsen, A.; Brzozowska, A.; Pietruszka, B.; Szczecinska, A.; Cano, N.; Meunier, N.; et al. The NU-AGE Consortium. Combating inflammaging through a Mediterranean whole diet approach: the NU-AGE project's conceptual framework and design. Mech. Ageing Dev. 2014, 136-137, 3-13.
218. Berendsen, A.; Santoro, A.; Pini, E.; Cevenini Ostan, R.; Pietruszka, B.; Rolf, K.; Cano, N.; Caille, A.; Lyon-Belgy, N.; Fairweather-Tait, S.; et al. A randomized trial on the effect of a full dietary intervention on ageing in European elderly people: Design of the NU-AGE dietary intervention study. Mech. Ageing Dev. 2013, 134, 523-530.
219. Calçada, D.; Vianello, D.; Giampieri, E.; Sala, C.; Castellani, G.; de Graaf, A.; Kremer, B.; van Ommen, B.; Feskens, E.; Santoro, A.; et al. The role of low-grade inflammation and metabolic flexibility in aging and nutritional modulation thereof: a systems biology approach. Mech. Ageing Dev. 2014, 136-137, 138-147.
220. Mediterranean diet and inflammaging in the elderly: The European project NU-AGE. Mech. Ageing Dev. 2014, 136-137.
221. Hughes, V. Microbiome: Cultural differences. Nature 2012, 492, S14-S15.